Arcellx Inc (ACLX)
87.22
0.00 (0.00%)
USD |
NASDAQ |
Nov 21, 16:00
87.15
-0.07
(-0.08%)
After-Hours: 20:00
Arcellx Shareholders Equity (Quarterly): 483.02M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 483.02M |
| June 30, 2024 | 487.16M |
| March 31, 2024 | 496.57M |
| December 31, 2023 | 485.38M |
| September 30, 2023 | 266.13M |
| June 30, 2023 | 293.67M |
| March 31, 2023 | 303.72M |
| Date | Value |
|---|---|
| December 31, 2022 | 204.95M |
| September 30, 2022 | 236.28M |
| June 30, 2022 | 315.96M |
| March 31, 2022 | 221.59M |
| December 31, 2021 | -121.52M |
| September 30, 2021 | -103.80M |
| December 31, 2020 | -63.72M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-121.52M
Minimum
Dec 2021
496.57M
Maximum
Mar 2024
250.39M
Average
279.90M
Median
Shareholders Equity (Quarterly) Benchmarks
| Boston Scientific Corp | 20.71B |
| AbbVie Inc | 6.032B |
| NovaBay Pharmaceuticals Inc | 1.072M |
| Palatin Technologies Inc | -7.686M |
| iBio Inc | 17.75M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 764.91M |
| Total Liabilities (Quarterly) | 281.89M |
| Current Ratio | 4.286 |